Fibroblast growth factor-2 mediates pressure-induced hypertrophic response

Journal of Clinical Investigation

Volumn 104, Issue 6, 1999, Pages 709-719

  Schultz, Jo El J ^a   Witt, Sandra A ^b   Nieman, Michelle L ^a   Reiser, Peter J ^c   Engle, Sandra J ^a   Zhou, Ming ^a,d   Pawlowski, Sharon A ^a   Lorenz, John N ^a   Kimball, Thomas R ^b   Doetschman, Thomas ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DOBUTAMINE; FIBROBLAST GROWTH FACTOR 2; MESSENGER RNA; MYOSIN HEAVY CHAIN;

ANIMAL MODEL; ARTICLE; ECHOCARDIOGRAPHY; HEART HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HEMODYNAMIC PARAMETERS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

EID: 0032748024     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7315     Document Type: Article

References (64)

1. Grossman, W. 1980. Cardiac hypertrophy: useful adaptation or pathologic process? Am. J. Med. 69:576-584.
2. Grossman, W., Jones, D., and McLaurin, L.P. 1975. Wall stress and patterns of hypertrophy in the human left ventricle. J. Clin. Invest. 56:56-64.
3. Lompre, A.M., Mercadier, J.J., and Schwartz, K. 1991. Changes in gene expression during cardiac growth. Int. Rev. Cytol. 124:137-186.
4. Parker, T.G., Packer, S.E., and Schneider, M.D. 1990. Peptide growth factors can provoke "fetal" contractile protein gene expression in rat cardiac myocytes. J. Clin. Invest. 85:507-514.
5. Bogoyevitch, M.A., et al. 1994. Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy. J. Biol. Chem. 269:1110-1119.
6. Harder, B.A., Schaub, M.C., Eppenberger, H.M., and Eppenberger-Eberhardt, M. 1996. Influence of fibroblast growth factor (bFGF) and insulin-like growth factor (IGF-I) on cytoskeletal and contractile structures and on atrial natriuretic factor (ANF) expression in adult rat ventricular cardiomyocytes in culture. J. Mol. Cell. Cardiol 28:19-31.
7. Kaye, D., et al. 1996. Role of transiently altered sarcolemmal membrane permeability and basic fibroblast growth factor release in the hypertrophic response of adult rat ventricular myocytes to increased mechanical activity in vitro. J. Clin. Invest. 97:281-291.
8. Hefti, M.A., Harder, B.A., Eppenberger, H.M., and Schaub, M.C. 1997. Signaling pathways in cardiac myocyte hypertrophy. J. Mol. Cell. Cardiol. 29:2873-2892.
9. Tomita, Y., et al. 1997. Increased accumulation of acidic fibroblast growth factor in left ventricular myocytes of patients with idiopathic cardiomyopathy. Am. Heart J. 134:779-786.
10. Scheinowitz, M., et al. 1998. Basic fibroblast growth factor induces myocardial hypertrophy following acute infarction in rats. Exp. Physiol. 83:585-593.
11. Izumo, S., et al. 1987. Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy. Interaction between hemodynamic and thyroid hormone-induced signals. J. Clin. Invest. 79:970-977.
12. Schwartz, K., et al. 1986. Alpha-skeletal muscle actin mRNA's accumulate in hypertrophied adult rat hearts. Circ. Res. 59:551-555.
13. Schoenfeld, J.R., et al. 1998. Distinct molecular phenotypes in murine cardiac muscle development, growth, and hypertrophy. J. Mol. Cell. Cardiol. 30:2269-2280.
14. Corda, S., et al. 1997. Trophic effect of human pericardial fluid on adult cardiac myocytes. Differential role of fibroblast growth factor-2 and factors related to ventricular hypertrophy. Circ. Res. 81:679-687.
15. Scheinowitz, M., Abramov, D., Kotlyar, A., Savion, N., and Eldar, M. 1998. Continuous administration of insulin-like growth factor-I and basic fibroblast growth factor does not affect left ventricular geometry after acute myocardial infarction in rats. Int. J. Cardiol. 63:217-221.
16. Zhou, M., et al. 1998. Fibroblast growth factor 2 control of vascular tone. Nat. Med. 4:201-207.
17. Dono, R., Texido, G., Dussel, R., Ehmke, H., and Zeller, R. 1998. Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice. EMBO J. 17:4213-4225.
18. Ortega, S., Ittmann, M., Tsang, S.H., Ehrlich, M., and Basilico, C. 1998. Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc. Natl. Acad. Sci. USA. 95:5672-5677.
19. Hogan, B., Constantini, F., and Lacy, E. 1986. Manipulating the mouse embryo: a laboratory manual. Cold Spring Harbor Laboratory Press. Plainview, NY.1-332.
20. Sahn, D.J., DeMaria, A., Kisslo, J., Weyman, A., 1978. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 58:1072-1083.
21. Devereux, R.B., et al. 1986. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am. J. Cardiol. 57:450-458.
22. Lorenz, J.N., and Robbins, J. 1997. Measurement of intraventricular pressure and cardiac performance in the intact closed-chest anesthetized mouse. Am. J. Physiol. 272:H1137-H1146.
23. Robbins, J., Gulick, J., Sanchez, A., Howles, P., and Doetschman, T. 1990. Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro. J. Biol. Chem. 265:11905-11909.
24. Sambrook, J., Fritsch, E.F., and Maniatis, T. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, NY. 1-332.
25. Reiser, P.J., and Kline, W.O. 1998. Electrophoretic separation and quantitation of cardiac myosin heavy chain isoforms in eight mammalian species. Am. J. Physiol. 274:H1048-H1053.
26. Thoss, K., and Roth, J. 1977. The use of fluorescein isothiocyanate labelled lectins for immuno-histological demonstration of saccharides. III. Studies by use of Ricinus communis lectin and wheat germ agglutinin. Exp. Pathol. (Jena). 14:215-219.
27. D'Angelo, D.D., et al. 1997. Transgenic Galphaq overexpression induces cardiac contractile failure in mice. Proc Natl. Acad. Sci. USA. 94:8121-8126.
28. Sakata, Y., Hoit, B.D., Liggett, S.B., Walsh, R.A., and Dorn, G.W. 1998. Decompensation of pressure-overload hypertrophy in G alpha q-over-expressing mice. Circulation. 97:1488-1495.
29. Engle, S.J., et al. 1999. Transforming growth factor β1 suppresses non-metastatic colon cancer at an early stage of tumorigenesis. Cancer Res. 59:3379-3386.
30. Manning, W.J., Wei, J.Y., Katz, S.E., Litwin, S.E., and Douglas, P.S. 1994. In vivo assessment of LV mass in mice using high-frequency cardiac ultrasound: necropsy validation. Am. J. Physiol. 266:H1672-H1675.
31. Gardin, J.M., Siri, F.M., Kitsis, R.N., Edwards, J.G., and Leinwand, L.A. 1995. Echocardiographic assessment of left ventricular mass and systolic function in mice. Circ. Res. 76:907-914.
32. Hartley, C.J., Michael, L.H., and Entman, M.L. 1995. Noninvasive measurement of ascending aortic blood velocity in mice. Am. J. Physiol. 268:H499-H505.
33. Hoit, B.D., Khoury, S.F., Kranias, E.G., Ball, N., and Walsh, R.A. 1995. In vivo echocardiographic detection of enhanced left ventricular function in gene-targeted mice with phospholamban deficiency. Circ. Res. 77:632-637.
34. Friberg, P., and Adams, M.A. 1990. Cardiac and vascular structural adaptation in experimental hypertension. Eur. Heart J. 11(Suppl. G):65-71.
35. Ganau, A., et al. 1992. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am. Coll. Cardiol. 19:1550-1558.
36. Ganau, A., and Devereux, R.B. 1994. Ventricular patterns in hypertensive patients: pathogenesis, treatment and prognosis. Prim. Cardiol. 20:19-27.
37. Mason, I.J. 1994. The ins and outs of fibroblast growth factors. Cell. 78:547-552.
38. McNeil, P.L., Muthukrishnan, L., Warder, E., and D'Amore, P.A. 1989. Growth factors are released by mechanically wounded endothelial cells. J. Cell Biol. 109:811-822.
39. Clarke, M.S., Caldwell, R.W., Chiao, H., Miyake, K., and McNeil, P.L. 1995. Contraction-induced cell wounding and release of fibroblast growth factor in heart. Circ. Res. 76:927-934.
40. Lembo, G., Hunter, J.J., and Chien, K.R. 1995. Signaling pathways for cardiac growth and hypertrophy. Recent advances and prospects for growth factor therapy. Ann. NY Acad. Sci. 752:115-127.
41. Quinkler, W., et al. 1989. Isolation of heparin-binding growth factors from bovine, porcine and canine hearts. Eur. J. Biochem. 181:67-73.
42. Kardami, E., and Fandrich, R.R. 1989. Basic fibroblast growth factor in atria and ventricles of the vertebrate heart. J. Cell Biol. 109:1865-1875.
43. Kardami, E., et al. 1995. Regulation of basic fibroblast growth factor (bFGF) and FGF receptors in the heart. Ann. NY Acad. Sci. 752:353-369.
44. Kardami, E., et al. 1991. Biochemical and ultrastructural evidence for the association of basic fibroblast growth factor with cardiac gap junctions. J. Biol. Chem. 266:19551-19557.
45. Casscells, W., et al. 1990. Isolation, characterization, and localization of heparin-binding growth factors in the heart. J. Clin. Invest. 85:433-441.
46. Sasaki, H., et al. 1989. Purification of acidic fibroblast growth factor from bovine heart and its localization in the cardiac myocytes. J. Biol. Chem. 264:17606-17612.
47. Weiner, H.L., and Swain, J.L. 1989. Acidic fibroblast growth factor mRNA is expressed by cardiac myocytes in culture and the protein is localized to the extracellular matrix. Proc. Natl. Acad. Sci. USA. 86:2683-2687.
48. Engelmann, G.L., Dionne, C.A., and Jaye, M.C. 1993. Acidic fibroblast growth factor and heart development. Role in myocyte proliferation and capillary angiogenesis. Circ. Res. 72:7-19.
49. Mason, I.J., Fuller-Pace, F., Smith, R., and Dickson, C. 1994. FGF-7 (keratinocyte growth factor) expression during mouse development suggests roles in myogenesis, forebrain regionalisation and epithelial-mesenchymal interactions. Mech. Dev. 45:15-30.
50. Beer, H.D., et al. 1997. Mouse fibroblast growth factor 10: cDNA cloning, protein characterization, and regulation of mRNA expression. Oncogene. 15:2211-2218.
51. Tagashira, S., Harada, H., Katsumata, T., Itoh, N., and Nakatsuka, M. 1997. Cloning of mouse FGF10 and up-regulation of its gene expression during wound healing. Gene. 197:399-404.
52. Hartung, H., et al. 1997. Murine FGF-12 and FGF-13: expression in embryonic nervous system, connective tissue and heart. Mech. Dev. 64:31-39.
53. Miyake, A., et al. 1998. Structure and expression of a novel member, FGF-16, on the fibroblast growth factor family. Biochem. Biophys. Res. Commun. 243:148-152.
54. Maruoka, Y., et al. 1998. Comparison of the expression of three highly related genes, Fgf8, Fgf17 and Fgf18, in the mouse embryo. Mech. Dev. 74:175-177.
55. Liu, L., et al. 1995. Adult cardiomyocytes express functional high-affinity receptors for basic fibroblast growth factor. Am. J. Physiol. 268:H1927-H1938.
56. Harada, K., et al. 1998. Pressure overload induces cardiac hypertrophy in angiotensin II type 1A receptor knockout mice. Circulation. 97:1952-1959.
57. Parker, T.G., Chow, K.L., Schwartz, R.J., and Schneider, M.D. 1990. Differential regulation of skeletal alpha-actin transcription in cardiac muscle by two fibroblast growth factors. Proc. Natl. Acad. Sci. USA. 87:7066-7070.
58. Schneider, M.D., McLellan, W.R., Black, F.M., and Parker, T.G. 1992. Growth factors, growth factor response elements, and the cardiac phenotype. Basic Res. Cardiol. 87(Suppl. 2):33-48.
59. Schneider, M.D., Kirshenbaum, L.A., Brand, T., and MacLellan, W.R. 1994. Control of cardiac gene transcription by fibroblast growth factors. Mol. Reprod. Dev. 39:112-117.
60. Buttrick, P.M., Kaplan, M., Leinwand, L.A., and Scheuer, J. 1994. Alterations in gene expression in the rat heart after chronic pathological and physiological loads. J. Mol. Cell. Cardiol. 26:61-67.
61. Calderone, A., Takahashi, N., Izzo, N.J.J., Thaik, C.M., and Colucci, W.S. 1995. Pressure- and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAs. Circulation. 92:2385-2390.
62. King, K.L., et al. 1998. Phenylephrine, endothelin, prostaglandin F2alpha' and leukemia inhibitory factor induce different cardiac hypertrophy phenotypes in vitro. Endocrine. 9:45-55.
63. Vikstrom, K.L., Bohlmeyer, T., Factor, S.M., and Leinwand, L.A. 1998. Hypertrophy, pathology, and molecular markers of cardiac pathogenesis. Circ. Res. 82:773-778.
64. Dorn, G.W., Robbins, J., Ball, N., and Walsh, R.A. 1994. Myosin heavy chain regulation and myocyte contractile depression after LV hypertrophy in aortic-banded mice. Am. J. Physiol. 267:H400-H405.